A39T (p.Ala39Thr) variant of UMOD (Uromodulin)

A39T (p.Ala39Thr) in UMOD (Uromodulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Familial juvenile hyperuricemic nephropathy type 1; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.75 / 1. The record also includes population frequency data and structural context.

A39T (p.Ala39Thr) variant details